Dunn, Shanade
Eberlein, Cath
Yu, Jason
Gris-Oliver, Albert http://orcid.org/0000-0003-1802-9541
Ong, Swee Hoe
Yelland, Urs
Cureton, Natalie
Staniszewska, Anna
McEwen, Robert
Fox, Millie http://orcid.org/0000-0003-4167-1620
Pilling, James
Hopcroft, Philip
Coker, Elizabeth A.
Jaaks, Patricia
Garnett, Mathew J. http://orcid.org/0000-0002-2618-4237
Isherwood, Beverley
Serra, Violeta http://orcid.org/0000-0001-6620-1065
Davies, Barry R. http://orcid.org/0000-0002-5414-9113
Barry, Simon T. http://orcid.org/0000-0002-8511-0588
Lynch, James T.
Yusa, Kosuke http://orcid.org/0000-0002-3442-021X
Funding for this research was provided by:
AstraZeneca
Article History
Received: 3 May 2022
Revised: 12 September 2022
Accepted: 21 September 2022
First Online: 14 October 2022
Competing interests
: SD, CE, UY, NC, AS, RMcE, MF, JP, PH, BI, BRD, SB, JTL are current or former AstraZeneca employees and shareholders and may own stock or stock options.